Congenital Myotonic Dystrophy type 1: prenatal manifestations regarding a case

Authors

DOI:

https://doi.org/10.56294/piii2023102

Keywords:

Myotonic Dystrophy type 1, Congenital Myotonic Dystrophy, Genetic Anticipation

Abstract

Introductions: myotonic dystrophy type 1 is a genetic disorder with great clinical variability in which there is a positive association between the number or size of the cytosine, thymine, guanine triplet repeats and the severity of the manifestations. The disorder exhibits an intergenerational anticipation phenomenon that explains the earlier age of onset of signs and the greater expression of clinical signs. Objetive: to describe the prenatal manifestations of myotonic dystrophy type 1.  Clinical case: 22-year-old female patient with a diagnosis of DM1 since she was 6 years old and with a family history of the disorder through the mother's line who came to the clinic with a 22-week pregnancy. Multiple signs were reported when performing prenatal fetal ultrasonography due to: presentation maintained in the pelvic region, slight ventriculomegaly, lower limbs extended and with ventral flexion on the trunk as well as both equinus feet. The birth occurred with a gestation period of 33.6 weeks, the Apgar test was 3-3-3, birth weight 2450 gr. Conclusions: the severity of the congenital form of myotonic dystrophy type 1 requires close monitoring by a multidisciplinary team that extends from the preconception stage, to detect the possible complications described that worsen the quality of life of patients and their families, and may even to the death of both the mother and the newborn, especially during the first year of life.

References

Johns Hopkins University. Dystrophia Myotonica, Steinert Disease, DM1. 2020 Baltimore: University; 2020 [acceso 20/03/2020]. Disponible en: https://www.omim.org/entry/160900

Bird TD. Myotonic Dystrophy Type 1. Gene Reviews. 2019 [acceso 20/03/2020];17. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK1165/

Q. Liao, Y. Zhang, J. He, K. Huang. Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis. Neuroepidemiology [Internet]. 2022 [citado 09/01/2023]; 56 (3): [aprox. 10p.]. Disponible en: https://karger.com/ned/article/56/3/163/825254/Global-Prevalence-of-Myotonic-Dystrophy-An-Updated

Gutiérrez Gutiérrez G, Díaz Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, et al. Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert. Med Clin. 2019 [acceso 14/03/2020]. Disponible en: https://www.elsevier.es/es-revista-neurologia-295-avance-resumen-guia-clinica-el-diagnostico-seguimiento-S0213485319300192

Morton A. Myotonic disorders and pregnancy. Obstet Med [Internet]. 2020 [citado 09/01/2021]; 13(1):[aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133106/

Saito Y, Matsumura K, Kageyama M, Kato Y, Ohta E, Sumi K, et al. Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy. BMC Res Notes [Internet]. 2020 [citado 09/01/2021];13:[aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379817/

Ho G, Cardamone M, Farrar M. Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions. World J Clin Pediatr [Internet]. 2015 [citado 09/01/2019]; 4(4): [aprox. 15p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637811

Johnson NE, Aldana EZ, Angeard N, Ashizawa T, Berggren KN, Marini Bettolo C, et al. Consensus based care recommendations for congenital and childhood onset myotonic dystrophy type 1. Neurol Clin Pract. 2019 [acceso 25/03/2020];9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814415/

Licourt Otero D, Travieso Téllez A, Orraca Castillo M, Sainz Padrón L. Expresión clínica de distrofia miotónica congénita Revista Cubana de Pediatría [Internet]. 2020 [citado 09/01/2022]; 92(3): [aprox. 9p.]. Disponible en: http://scielo.sld.cu/pdf/ped/v92n3/1561-3119-ped-92-03-e1105.pdf

Sánchez Marín JP, Sienes Bailo R. Lahoz Alonso JL, Capablo Liesa J, Gazulla Abio JA, Giménez Muñoz PJ, et al. Distrofia miotónica tipo 1: 13 años de experiencia en un hospital terciario. Estudio clínico y epidemiológico. Correlación genotipo-fenotipo. Rev Neurología. 2021 [acceso 10/02/2022]. Disponible en: https://www.elsevier.es/es-revista-neurologia-295-avanceresumen-distrofia-miotonica-tipo1-13anos-experiencia-S0213485321000505

I Cascais et al. Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital. European Journal of Paediatric Neurology [Internet]. 2024 [citado 09/03/2024]; 48: [aprox. 4p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S109037982300185X

Sánchez-Tejerina D, Palomino Doza J, Valverde-Gómez M, Ruiz-Curiel A, Salguero-Bodes R, Hernández-Voth A, et al. Distrofia miotónica de tipo 1: una serie de 107 pacientes. Rev Neurol [Internet]. 2021 [citado 09/01/2022]; 73(10):[aprox. 8p.]. Disponible en: https://neurologia.com/articulo/2021366

Rodríguez Roque M, López Argüelles J, Sánchez Lozano A, Herrera Alonso D, Sosa Águila L, Rodríguez Ramírez Y. Distrofia miotónica de Steiner en una familia. Presentación de casos. Medisur [Internet]. 2020 [citado 09/01/2022]; 18(1): [aprox. 7p.]. Disponible en: https://medisur.sld.cu/index.php/medisur/article/view/4431/3030

Downloads

Published

2024-04-05

How to Cite

1.
Licourt Otero D, Toledo Licourt M, Candelaria Gómez B, Díaz Hernández IA. Congenital Myotonic Dystrophy type 1: prenatal manifestations regarding a case. SCT Proceedings in Interdisciplinary Insights and Innovations [Internet]. 2024 Apr. 5 [cited 2024 Nov. 21];1:102. Available from: https://proceedings.ageditor.ar/index.php/piii/article/view/26